Neuroglee recently raised $10 million in funding and struck a partnership with Mayo Clinic. It’s building a digital therapeutic and virtual programs for people with mild cognitive impairment.
Engine Biosciences closed a $43 million Series A financing that the startup will apply to its artificial intelligence-based technology for drug discovery. The company analyzes genetic interactions, "deciphering biology" to find new cancer drugs.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
The German drugmaker announced a partnership with Enleofen to develop the company's suite of preclinical antibodies targeting IL-11 in diseases like NASH.
The money will be used in part to establish a CLIA-certified a lab in the San Francisco area that would allow for speedier results to its U.S. customers.
The agency announced it had authorized Vela Diagnostics' Sentosa SQ HIV Genotyping Assay, designed to help healthcare providers tailor antiviral therapy based on the presence of viral resistance mutations.
While the devices themselves will be free for users, additional health coaching services and software offerings will require a monthly fee.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The company is moving its headquarters from Singapore to Boston alongside the capital raise.
The deal expands access to MyDoc’s virtual managed care platform to more than 14,000 UST employees across the Indian cities of Bangalore and Mumbai.
The company plans to use the funding to advance clinical candidates and expand its portfolio, which touches a wide range of diseases.
Physicians are not only becoming more proficient with EHRs, they are using their systems for more than just reference. That's the conclusion of a new Accenture survey of more than 2,600 doctors in Australia, Brazil, England, Norway, Singapore and the U.S.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
In a nod towards the growing interest by digital health companies in the Asian market, a physician scheduling service for expatriates in eight Asian countries has raised a $8.6M Series A round, according to a report by TechCrunch. The publication noted that this has been the largest Series A round to date for a digital […]
Amaranth Medical, a medical device company with roots in California and Singapore, has raised $20 million for a series B round. The money will support continued development of the company’s bioresorbable scaffold (a dissolving stent) technology and the CE Mark approval process. General Manager and Chief Technical Officer Kamal Ramzipoor compared the stent to a cast. […]
Duke University researchers have found that cells that play a role in triggering a response to bacteria and pathogens could also have a role in attacking dengue fever, a tropical disease for which there is no vaccine. A Duke research team at the Duke-NUS Graduate Medical School in Singapore studied mast cells in mice. Mast […]